Szerző: " Guclu Salih Z"

Soria Jean-Charles; Felip Enriqueta; Cobo Manuel; Lu Shun; Syrigos Konstantinos; Lee Ki Hyeong; Goeker Erdem; Georgoulias Vassilis; Li Wei; Isla Dolores; Guclu Salih Z; Morabito Alessandro; Min Young J; Ardizzoni Andrea; Gadgeel Shirish M; Wang Bushi; Chand Vikram K; Goss Glenwood D; Kollaborációs szervezet: LUX-Lung 8 Investigators; Somfay Attila; et al. (kollab. közrem.): Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
LANCET ONCOLOGY, 16 (8). pp. 897-907. ISSN 1470-2045 (2015)